Resources
About Us
Home Report
Store
Europe Single-use Bioreactors Market
Europe Single-use Bioreactors Market by Product [Systems, Media Bags (2D, 3D), Filtration Assemblies], Type [Stirred Tank, Wave Induced], Cell [Mammalian, Bacterial, Yeast], Application [Commercial (Mab, Vaccine), Research], End User - Forecast to 2030
Report ID:MRHC - 104869 Pages: 150 Jun-2024 Formats*: PDF Category: Healthcare Delivery: 24 to 72 HoursThe Europe Single-use Bioreactors Market is projected to reach $3.34 billion by 2030, at a CAGR of 15.3% from 2024 to 2030. Single-use bioreactors, also called disposable bioreactors, are made of disposable bags instead of a culture vessel. These bioreactors eliminate the need for expensive and bulky clean-in-place (CIP) or steam-in-place (SIP) systems and offer flexibility and a low risk of contamination, contributing to their adoption by pharma & biotech companies. Along with this, end users' manufacturing and R&D capacity expansion increases the demand for the products in the region. For instance, in September 2022, Viralgen Vector Core (Viralgen), a member of the Bayer worldwide group of companies, received Certified Good Manufacturing Practices (cGMP) certification for human medicinal products, investigational medicinal products, and sterile or biologically active substances.
The rapid adoption of disposable technology in the pharmaceutical and biotechnology industry, growing demand for biopharmaceuticals, government support for the production & use of biopharma products for various health indications, and capacity expansion of biopharmaceutical plants are some of the major factors driving the growth of the Europe single-use bioreactors market.
Click here to: Get a Free Sample Copy of this Report
Expansion of Manufacturing Capacity by CDMOs & CROs and Increasing Interest of U.S. Companies to Invest in European Companies are Driving the Growth of this Market
Rising demand for biologicals and biosimilars; the rising cost of drug development; the growing demand for cell therapies, gene therapies, and personalized medicines; and the growing consolidation among CDMOs & CROs supported the adoption of single-use bioreactors for end users in the region.
CDMOs support pharmaceutical & biotechnology firms through outsourced research and manufacturing services on a contractual basis. Pharmaceutical and biopharmaceutical companies depend on CDMOs to reduce R&D efforts, avoid the high fixed costs of in-house development, and harness the manufacturing capabilities and expertise required to drive their molecules through clinical development. These organizations offer a broad range of services in preclinical research, clinical research, assay development, clinical trial management, and bioproduction.
Pharmaceutical & biopharmaceutical companies are increasingly adopting drug discovery outsourcing to reduce the overall drug development time & related costs, improve R&D productivity, optimize operational flexibilities, and increase their profit margins. Looking at the growing market of CDMOs, various key players in the life science industry are taking steps toward acquiring CDMOs. In May 2024, eureKING (France) acquired Skyepharma (CDMO) (France) to build biotherapies segments and expand its biomanufacturing capacity. The acquisitions of CDMOs by large companies lead to the expansion of the capacities of CDMOs, which in turn is beneficial for the single-use bioreactors market. Also, the expansion by CDMOs for biomanufacturing supports the growth of this segment. For instance,
- In July 2021, Viralgen VC (Spain) opened its new manufacturing facility in Basque, Italy. This facility is associated with adeno-associated virus gene therapy production.
- In July 2021, Catalent, Inc. (U.S.) invested USD 100 million to expand the capacity of a facility in Anagni, Italy, by adding biological drug substance manufacturing capabilities.
Thus, such expansion increases demand for biopharma products, thereby driving the Europe single-use bioreactors market for these end users.
Government Initiatives to Increase Bioproduction is an Opportunity for the Players in this Market
European governments are investing in the pharma & biopharma industry to boost R&D and bioproduction. The government and other public groups and enterprises are providing funding and grants for research and development to pharmaceutical, biopharmaceutical, and biotech companies, thereby helping to grow the biopharmaceutical market and increasing demand for single-use bioreactors. For instance,
- In 2021, the U.K. Biotechnology and Biological Sciences Research Council (BBSRC), which provides USD 101 million (GBP 57 million) each year for R&D in biotechnology and biological sciences, has adopted a new strategy for investment. Along with this strategy, the U.K. government aims to increase R&D spending to 2.4% of gross domestic product by 2027.
- In 2021, the Government of Ireland allocated USD 975.2 billion (EUR 869.2 billion) for research and development to software, medical devices, manufacturing, and pharmaceutical companies.
- In 2021, the Prime Minister of the U.K. hosted an event with large biopharmaceutical companies, including AstraZeneca (U.K.), GlaxoSmithKline (U.K.), and Pfizer (U.K.), to strengthen future pandemic responses. This summit was after announcing new investments, which swooped in USD 6.7 billion (GBP 5 billion) from July 2021 to December 2021.
- In 2021, the Irish government provided funding of USD 4.9 billion (EUR 4 billion) for R&D to ICON plc (Ireland), a drug development solutions and services provider to the pharmaceutical, biotechnology, and medical device industries. This funding was awarded for clinical trials to expand patient access to clinical research through technology.
Key Findings in the Europe Single-use Bioreactors Market Study:
Among Products, the Media Bags Segment is Projected to Register the Highest CAGR
Advantages like high flexibility, low levels of extractable and leachable and high product stability during storage compared to culture vessels supported the market growth. Also, the low risk of cross-contamination from batch to batch and product to product and eliminating the time and expense of sterilization-in-place (SIP) & clean-in-place (CIP) operations, optimizing capacity utilization, increase their adoption for bioprocessing.
Among Types, the Wave-induced Bioreactors Segment is Projected to Register the Highest CAGR
Wave-induced bioreactor systems offer various benefits, like no need to rely on oxygen bubbles for culture aeration, generation of rocking motion to meet the required amount of oxygen for cell growth, and a large surface-to-volume ratio. These benefits lead to driving the market at the highest growth rate.
In contrast to conventional stirred tank bioreactors, wave-induced bioreactor systems improve fluid turnover and minimize shear forces compared to stirred tanks. Such flow conditions reportedly produce better cell suspension and reduce the risk of cell damage and thus have enabled rocking-motion bioreactors to reach higher maximum cell densities than traditional spinner flasks.
Among Cell Types, in 2024, the Mammalian Cells Segment is Expected to Account for the Largest Share
In 2024, the mammalian cells segment is expected to account for the largest share of the market. Increased need for mAbs production with consistent quality and preference for culturing in large-scale suspension bioreactors to increase bioproduction supported the share. Also, Demand for high throughput operations in cell culture processing will continue to drive the single-use bioreactor market for mammalian cells.
The Research Bio-production Segment is Projected to Register the Highest CAGR
Among the application, the research bio-production segment is projected to register the highest CAGR owing to growing support from regulatory agencies & companies’ initiatives. For instance, in January 2021, the Circa Group Europe Limited (Ireland) invested USD 2.2 billion (EUR 2 billion) in biopharmaceutical research and development through IDA Ireland’s client companies annually. Thus, such an investment plan helps boost the demand for biopharma products in the European region, thereby driving the market.
Among End Users, in 2024, the Pharmaceutical & Biopharmaceutical Companies Segment is Expected to Account for the Largest Share of the Market
The large market share of this segment is attributed to the rise in R&D activities, the focus of U.S.-based companies to expand their manufacturing capacities in European countries, the high adoption of bioreactors in pharmaceutical laboratories, and concerns over flexibility, sterility, cost efficiency, and enhanced productivity.
Also, increasing demand for biopharmaceutical products, growing adoption of single-use products, growing incidence & prevalence of various chronic diseases, rising R&D expenditure by pharmaceutical & biotechnology companies, and recent launches of biologics for chronic & rare diseases raise the growth of the market for them.
Germany: In 2024, to Account for the Largest Share of the Market
The factors supporting the large share of this market include increasing pharmaceutical export, government grants, growth in immunization, and funding to biotech & biopharmaceutical companies expanding their capacities for biologics to meet the market's increasing demand. Being one of the largest biopharma markets in the EU region and the presence of key players in the country supported their large share in the market.
Key Players
The report includes a competitive landscape based on an extensive assessment of the key growth strategies adopted by leading market participants in the last 3 to 4 years. The key players profiled in the Europe single-use bioreactors market report are Merck KGaA (Germany), Danaher Corporation (U.S.), Sartorius AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Eppendorf AG (Germany), Solaris Biotechnology srl (Italy), Cellexus International Ltd. (U.K.) CESCO Bioengineering Co., Ltd. (Taiwan), PBS Biotech, Inc. (U.S.), Solida Biotech GmbH (Germany), and Infors AG (Switzerland).
Scope of the Report:
Europe Single-use Bioreactors Market, by Product
- Single-use Bioreactor Systems
- Upto 10L
- 11L-500L
- 501-1000L
- Above 1001L
- Media Bags
- 2D
- 3D
- Linear
- Filtration Assemblies
- Other Products
(Note: Other products include pumps, single-use vessels, tubing & connectors, gas components, rockers, cables, sensors/probes, and films.)
Europe Single-use Bioreactors Market, by Type
- Stirred-tank Bioreactors
- Wave-induced Bioreactors
- Other Types
(Note: Other types include hybrid bioreactors, bubble-column, and bioreactors with vertically perforated discs.)
Europe Single-use Bioreactors Market, by Cell Type
- Mammalian cells
- Bacterial Cells
- Yeast Cells
- Other Cell Types
(Note: Other cell types include plant cells and insect cells.)
Europe Single-use Bioreactors Market, by Application
- Commercial Bioproduction
- Monoclonal Antibody Production
- Vaccine Production
- Therapeutic Protein Production
- Cell & Gene Therapy
- Research Bioproduction
Europe Single-use Bioreactors Market, by End User
- Pharmaceutical and Biopharmaceutical Companies
- Contract Development and Manufacturing Organizations (CDMO) and Contract Research Organizations (CROs)
- Academic and Research Institutes
Europe Single-use Bioreactors Market, by Country
- Germany
- U.K.
- France
- Italy
- Switzerland
- Ireland
- Denmark
- Belgium
- Spain
- Rest of Europe
Key questions answered in the report:
This study offers a detailed assessment of the Europe single-use bioreactors market, including the market size & forecast for various segmentations, including product, type, cell type, application, and end user. The Europe single-use bioreactors market studied in this report also involves the value analysis of various segments and sub-segments of single-use bioreactors at country levels.
The Europe single-use bioreactors market is projected to reach $3.34 billion by 2030, at a CAGR of 15.3% during the forecast period.
Among the product, in 2024, the single-use bioreactor systems segment is expected to account for the largest share of the single-use bioreactors market.
Among the type, the wave-induced bioreactors segment is projected to register the highest CAGR over the forecast period. The advantages offered by these bioreactors over stirred-tank and increasing cell-based research supported the adoption are the key factors supporting market growth.
The growth of this market is driven by the increasing sales of drugs and support from government & regulatory authorities to promote the use of biopharmaceuticals for health indications. Various companies expanding their manufacturing capacities and operations offer significant opportunities for the players operating in this market.
The key players profiled in the Europe single-use bioreactors market report are Merck KGaA (Germany), Danaher Corporation (U.S.), Sartorius AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Eppendorf AG (Germany), Solaris Biotechnology srl (Italy), Cellexus International Ltd. (U.K.) CESCO Bioengineering Co., Ltd. (Taiwan), PBS Biotech, Inc. (U.S.), Solida Biotech GmbH (Germany), and Infors AG (Switzerland).
Germany and France are projected to offer significant growth opportunities to the market players due to government initiatives to promote biosimilars, increasing healthcare expenditure, and growing investment in biopharmaceutical companies to expand their operations and manufacturing capacities.
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency and Limitation
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research / Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for The Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Factor Analysis
4.3. Market Trends
4.3.1. Use of Hybrid Systems
4.3.2. Rising Focus on Continuous Bioprocessing
4.3.3. Shift Toward Bioprocessing 4.0
4.3.4. Integration of AI in Bioprocessing
4.4. Parent Market Analysis: European Biopharmaceutical Processing Equipment and Consumables Market
5. Europe Single-use Bioreactors Market Assessment, by Product
5.1. Overview
5.2. Single-use Bioreactor Systems
5.2.1. Upto 10 Liters Single-use Bioreactor Systems
5.2.2. 11–500 Liters Single-use Bioreactor Systems
5.2.3. 501–1000 Liters Single-use Bioreactor Systems
5.2.4. Above 1001 Liters Single-use Bioreactor Systems
5.3. Media Bags
5.3.1. 2D Media Bags
5.3.2. 3D Media Bags
5.3.3. Linear Media Bags
5.4. Filtration Assemblies
5.5. Other Products
6. Europe Single-use Bioreactors Market Assessment, by Type
6.1. Overview
6.2. Stirred-Tank Bioreactors
6.3. Wave-Induced Bioreactors
6.4. Other Single-use Bioreactors
7. Europe Single-use Bioreactors Market Assessment, by Cell Type
7.1. Overview
7.2. Mammalian Cells
7.3. Bacterial Cells
7.4. Yeast Cells
7.5. Other Cells
8. Europe Single-use Bioreactors Market Assessment, by Application
8.1. Overview
8.2. Commercial Bioproduction
8.2.1. Monoclonal Antibody Production
8.2.2. Therapeutic Protein Production
8.2.3. Vaccine Production
8.2.4. Cell and Gene Therapy
8.3. Research Bioproduction
9. Europe Single-use Bioreactors Market Assessment, by End User
9.1. Overview
9.2. Pharmaceutical and Biopharmaceutical Companies
9.3. Contract Development and Manufacturing Organizations & Contract Research Organizations
9.4. Academic & Research Institutes
10. Europe Single-use Bioreactors Market Assessment, by Country
10.1. Overview
10.2. Germany
10.3. France
10.4. U.K.
10.5. Italy
10.6. Switzerland
10.7. Spain
10.8. Ireland
10.9. Denmark
10.10. Belgium
10.11. Rest of Europe
11. Competition Analysis
11.1. Introduction
11.2. Key Growth Strategies
11.3. Vendor Benchmarking
11.4. Competitive Dashboard
11.4.1. Industry Leaders
11.4.2. Market Differentiators
11.4.3. Vanguards
11.4.4. Emerging Companies
12. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments, SWOT Analysis)
12.1. Thermo Fisher Scientific Inc.
12.2. Danaher Corporation
12.3. Merck KGaA
12.4. Eppendorf AG
12.5. Sartorius AG
12.6. Solaris Biotechnology srl (A Subsidiary of Donaldson Company, Inc.)
12.7. Cellexus International Ltd.
12.8. CESCO Bioengineering Co., Ltd.
12.9. Infors AG
12.10. PBS Biotech, Inc.
12.11. Solida Biotech GmbH
(Note: SWOT analysis is provided for leading 5 companies.)
13. Appendix
13.1. Available Customization
13.2. Related Reports
List of Tables
Table 1 Europe Single-use Bioreactors Market, by Product, 2021–2030 (USD Million)
Table 2 Europe Single-use Bioreactor Systems Market, by Type, 2021–2030 (USD Million)
Table 3 Europe Single-use Bioreactor Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 4 Companies offering Upto 10 Liters Single-use Bioreactor Systems
Table 5 Europe Upto 10 Liters Single-use Bioreactor Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 6 Vendors offering 11–500 Liters Single-use Bioreactor Systems
Table 7 Europe 11–500 Liters Single-use Bioreactor Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 8 Vendors offering 501–1000 Liters Single-use Bioreactor Systems
Table 9 Europe 501–1000 Liters Single-use Bioreactor Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 10 Vendors offering Above 1001 Liters Single-use Bioreactor Systems
Table 11 Europe Above 1001 Liters Single-use Bioreactor Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 12 Europe Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 13 Europe Single-use Bioreactor Media Bags Market, by Country/Region, 2021–2030 (USD Million)
Table 14 Europe Single-use 2D Media Bags Market, by Country/Region, 2021–2030 (USD Million)
Table 15 Europe Single-use 3D Media Bags Market, by Country/Region, 2021–2030 (USD Million)
Table 16 Europe Single-use Linear Media Bags Market, by Country/Region, 2021–2030 (USD Million)
Table 17 Europe Single-use Bioreactor Filtration Assemblies Market, by Country/Region, 2021–2030 (USD Million)
Table 18 Europe Other Single-use Bioreactor Products Market, by Country/Region, 2021–2030 (USD Million)
Table 19 Europe Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 20 Europe Stirred-Tank Single-use Bioreactors Market, by Country/Region, 2021–2030 (USD Million)
Table 21 Europe Wave-Induced Bioreactors Market, by Country/Region, 2021–2030 (USD Million)
Table 22 Europe Other Single-use Bioreactor Market, by Country/Region, 2021–2030 (USD Million)
Table 23 Europe Single-use Bioreactors Market, by Cell Type, 2021–2030 (USD Million)
Table 24 Europe Single-use Bioreactors Market for Mammalian Cells, by Country/Region, 2021–2030 (USD Million)
Table 25 Europe Single-use Bioreactors Market for Bacterial Cells, by Country/Region, 2021–2030 (USD Million)
Table 26 Europe Single-use Bioreactor Market for Yeast Cells, by Country/Region, 2021–2030 (USD Million)
Table 27 Europe Single-use Bioreactor Market for Other Cells, by Country/Region, 2021–2030 (USD Million)
Table 28 Europe Single-use Bioreactors Market, by Application, 2021–2030 (USD Million)
Table 29 Europe Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 30 Europe Single-use Bioreactors Market for Commercial Bioproduction, by Country /Region, 2021–2030 (USD Million)
Table 31 Europe Single-use Bioreactors Market for Monoclonal Antibody Production, by Country/Region, 2021–2030 (USD Million)
Table 32 Europe Single-use Bioreactors Market for Therapeutic Protein Production, by Country/Region, 2021–2030 (USD Million)
Table 33 Europe Single-use Bioreactors Market for Vaccine Production, by Country/Region, 2021–2030 (USD Million)
Table 34 Europe Single-use Bioreactors Market for Cell and Gene Therapy, by Country/Region, 2021–2030 (USD Million)
Table 35 Europe Single-use Bioreactors Market for Research Bioproduction, by Country/Region, 2021–2030 (USD Million)
Table 36 Europe Single-use Bioreactors Market, by End User, 2021–2030 (USD Million)
Table 37 Europe Single-use Bioreactors Market for Pharmaceutical and Biopharmaceutical Companies, by Country/Region, 2021–2030 (USD Million)
Table 38 Europe Single-use Bioreactors Market for CDMO & CRO, by Country/Region, 2021–2030 (USD Million)
Table 39 Europe Single-use Bioreactor Market for Academic & Research Institutes, by Country/Region, 2021–2030 (USD Million)
Table 40 Europe Single-use Bioreactors Market, by Country, 2021–2030 (USD Million)
Table 41 Europe: Single-use Bioreactors Market, by Product, 2021–2030 (USD Million)
Table 42 Europe: Single-use Bioreactor Systems Market, by Type, 2021–2030 (USD Million)
Table 43 Europe: Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 44 Europe: Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 45 Europe: Single-use Bioreactors Market, by Cell Type, 2021–2030 (USD Million)
Table 46 Europe: Single-use Bioreactors Market, by Application, 2021–2030 (USD Million)
Table 47 Europe: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 48 Europe: Single-use Bioreactors Market, by End User, 2021–2030 (USD Million)
Table 49 Germany: Single-use Bioreactors Market, by Product, 2021–2030 (USD Million)
Table 50 Germany: Single-use Bioreactors Systems Market, by Type, 2021–2030 (USD Million)
Table 51 Germany: Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 52 Germany: Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 53 Germany: Single-use Bioreactors Market, by Cell Type, 2021–2030 (USD Million)
Table 54 Germany: Single-use Bioreactors Market, by Application, 2021–2030 (USD Million)
Table 55 Germany: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 56 Germany: Single-use Bioreactors Market, by End User, 2021–2030 (USD Million)
Table 57 France: Single-use Bioreactors Market, by Product, 2021–2030 (USD Million)
Table 58 France: Single-use Bioreactors Systems Market, by Type, 2021–2030 (USD Million)
Table 59 France: Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 60 France: Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 61 France: Single-use Bioreactors Market, by Cell Type, 2021–2030 (USD Million)
Table 62 France: Single-use Bioreactors Market, by Application, 2021–2030 (USD Million)
Table 63 France: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 64 France: Single-use Bioreactors Market, by End User, 2021–2030 (USD Million)
Table 65 U.K.: Single-use Bioreactors Market, by Product, 2021–2030 (USD Million)
Table 66 U.K.: Single-use Bioreactors Systems Market, by Type, 2021–2030 (USD Million)
Table 67 U.K.: Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 68 U.K.: Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 69 U.K.: Single-use Bioreactors Market, by Cell Type, 2021–2030 (USD Million)
Table 70 U.K.: Single-use Bioreactors Market, by Application, 2021–2030 (USD Million)
Table 71 U.K.: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 72 U.K.: Single-use Bioreactors Market, by End User, 2021–2030 (USD Million)
Table 73 Italy: Single-use Bioreactors Market, by Product, 2021–2030 (USD Million)
Table 74 Italy: Single-use Bioreactors Systems Market, by Type, 2021–2030 (USD Million)
Table 75 Italy: Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 76 Italy: Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 77 Italy: Single-use Bioreactors Market, by Cell Type, 2021–2030 (USD Million)
Table 78 Italy: Single-use Bioreactors Market, by Application, 2021–2030 (USD Million)
Table 79 Italy: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 021–2030 (USD Million)
Table 80 Italy: Single-use Bioreactors Market, by End User, 2021–2030 (USD Million)
Table 81 Switzerland: Single-use Bioreactors Market, by Product, 2021–2030 (USD Million)
Table 82 Switzerland: Single-use Bioreactors Systems Market, by Type, 2021–2030 (USD Million)
Table 83 Switzerland: Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 84 Switzerland: Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 85 Switzerland: Single-use Bioreactors Market, by Cell Type, 2021–2030 (USD Million)
Table 86 Switzerland: Single-use Bioreactors Market, by Application, 2021–2030 (USD Million)
Table 87 Switzerland: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 88 Switzerland: Single-use Bioreactors Market, by End User, 2021–2030 (USD Million)
Table 89 Spain: Single-use Bioreactors Market, by Product, 2021–2030 (USD Million)
Table 90 Spain: Single-use Bioreactors Systems Market, by Type, 2021–2030 (USD Million)
Table 91 Spain: Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 92 Spain: Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 93 Spain: Single-use Bioreactors Market, by Cell Type, 2021–2030 (USD Million)
Table 94 Spain: Single-use Bioreactors Market, by Application, 2021–2030 (USD Million)
Table 95 Spain: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 96 Spain: Single-use Bioreactors Market, by End User, 2021–2030 (USD Million)
Table 97 Ireland: Single-use Bioreactors Market, by Product, 2021–2030 (USD Million)
Table 98 Ireland: Single-use Bioreactors Systems Market, by Type, 2021–2030 (USD Million)
Table 99 Ireland: Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 100 Ireland: Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 101 Ireland: Single-use Bioreactors Market, by Cell Type, 2021–2030 (USD Million)
Table 102 Ireland: Single-use Bioreactors Market, by Application, 2021–2030 (USD Million)
Table 103 Ireland: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 104 Ireland: Single-use Bioreactors Market, by End User, 2021–2030 (USD Million)
Table 105 Denmark: Single-use Bioreactors Market, by Product, 2021–2030 (USD Million)
Table 106 Denmark: Single-use Bioreactors Systems Market, by Type, 2021–2030 (USD Million)
Table 107 Denmark: Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 108 Denmark: Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 109 Denmark: Single-use Bioreactors Market, by Cell Type, 2021–2030 (USD Million)
Table 110 Denmark: Single-use Bioreactors Market, by Application, 2021–2030 (USD Million)
Table 111 Denmark: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 112 Denmark: Single-use Bioreactors Market, by End User, 2021–2030 (USD Million)
Table 113 Belgium: Single-use Bioreactors Market, by Product, 2021–2030 (USD Million)
Table 114 Belgium: Single-use Bioreactors Systems Market, by Type, 2021–2030 (USD Million)
Table 115 Belgium: Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 116 Belgium: Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 117 Belgium: Single-use Bioreactors Market, by Cell Type, 2021–2030 (USD Million)
Table 118 Belgium: Single-use Bioreactors Market, by Application, 2021–2030 (USD Million)
Table 119 Belgium: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 120 Belgium: Single-use Bioreactors Market, by End User, 2021–2030 (USD Million)
Table 121 RoE: Single-use Bioreactors Market, by Product, 2021–2030 (USD Million)
Table 122 RoE: Single-use Bioreactors Systems Market, by Type, 2021–2030 (USD Million)
Table 123 RoE: Single-use Bioreactor Media Bags Market, by Type, 2021–2030 (USD Million)
Table 124 RoE: Single-use Bioreactors Market, by Type, 2021–2030 (USD Million)
Table 125 RoE: Single-use Bioreactors Market, by Cell Type, 2021–2030 (USD Million)
Table 126 RoE: Single-use Bioreactors Market, by Application, 2021–2030 (USD Million)
Table 127 RoE: Single-use Bioreactors Market for Commercial Bioproduction, by Type, 2021–2030 (USD Million)
Table 128 RoE: Single-use Bioreactors Market, by End User, 2021–2030 (USD Million)
Table 129 Recent Developments, by Company, 2020–2024
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for This Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Europe Single-use Bioreactors Market, by Product, 2024 Vs. 2030 (USD Million)
Figure 8 Europe Single-use Bioreactors Market, by Type, 2024 Vs.2030 (USD Million)
Figure 9 Europe Single-use Bioreactors Market, by Cell Type, 2024 Vs. 2030 (USD Million)
Figure 10 Europe Single-use Bioreactors Market, by Application, 2024 Vs.2030 (USD Million)
Figure 11 Europe Single-use Bioreactors Market, by End User, 2024 Vs. 2030 (USD Million)
Figure 12 Europe Single-use Bioreactors Market, by Country, 2024 Vs. 2030 (USD Million)
Figure 13 Impact Analysis: Europe Single-use Bioreactors Market
Figure 14 Europe Prescription Drug Sales, 2014–2028 (USD Billion)
Figure 15 Europe Pharmaceutical R&D Spend, 2014-2028 (USD Billion)
Figure 16 Number of Biosimilars Approved in EU, 2014-2022
Figure 17 Europe Geriatric Population (Aged 60 Years & Above), 2019–2050
Figure 18 Europe Biopharmaceutical Processing Equipment and Consumables Market Size, 2022 Vs. 2029 (USD Million)
Figure 19 Europe Single-use Bioreactors Market, by Product, 2024–2030 (USD Million)
Figure 20 Europe Single-use Bioreactors Market, by Type, 2024–2030 (USD Million)
Figure 21 Europe Single-use Bioreactors Market, by Cell Type, 2024–2030 (USD Million)
Figure 22 Europe Single-use Bioreactors Market, by Application, 2024–2030 (USD Million)
Figure 23 Europe Single-use Bioreactors Market, by End User, 2024–2030 (USD Million)
Figure 24 Europe Single-use Bioreactors Market, by Country/Region, 2024 Vs. 2030 (USD Million)
Figure 25 Europe: Single-use Bioreactors Market Snapshot
Figure 26 Europe Single-use Bioreactors Market: Vendor Benchmarking, by Product
Figure 27 Competitive Dashboard: Europe Single-use Bioreactors Market
Figure 28 Thermo Fisher Scientific Inc.: Financial Overview (2022)
Figure 29 Danaher Corporation: Financial Overview (2022)
Figure 30 Merck KGaA: Financial Overview (2022)
Figure 31 Eppendorf AG: Financial Overview (2021)
Figure 32 Sartorius AG: Financial Overview (2022)
Author Name:
Proudly Partnering With Enterprises Around the Globe
Quick Contact
Related Reports
Europe IVD Market - Opportunity Analysis and Industry Forecast (2024-2030)
Published Date: Jul-2024
Europe LIMS Market - Opportunity Analysis and Industry Forecast (2024-2030)
Published Date: Jul-2024
Europe NGS Market - Opportunity Analysis and Industry Forecasts (2024-2030)
Published Date: Jul-2024
Bioreactors Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Jan-2024
Single-use Bioreactors Market - Global Opportunity Analysis and Industry Forecast (2023-2030)
Published Date: May-2023
